M320 (opioid)
Overview[edit]
M320 is a synthetic opioid analgesic that belongs to the orvinol class of compounds. It is known for its potent analgesic properties and is primarily used in research settings to study opioid receptor interactions and pain management mechanisms.
Chemical Structure[edit]

M320 is chemically classified as an orvinol derivative. The structure of M320 includes a complex arrangement of carbon, hydrogen, and nitrogen atoms, which contribute to its high affinity for opioid receptors. The presence of specific functional groups in its structure is responsible for its potent activity and selectivity.
Mechanism of Action[edit]
M320 exerts its effects by binding to the mu-opioid receptor (MOR), which is a type of G protein-coupled receptor (GPCR) located in the central nervous system. Upon binding, M320 activates the receptor, leading to a cascade of intracellular events that result in the inhibition of neurotransmitter release and modulation of pain perception.
Pharmacological Effects[edit]
The primary pharmacological effect of M320 is its potent analgesic action. It is capable of producing significant pain relief by altering the perception of pain in the brain and spinal cord. Additionally, like other opioids, M320 may induce side effects such as sedation, respiratory depression, and euphoria.
Research Applications[edit]
M320 is utilized in preclinical research to explore the pharmacodynamics and pharmacokinetics of opioid compounds. It serves as a tool for understanding the structure-activity relationship (SAR) of opioids and for developing new analgesics with improved safety profiles.
Safety and Toxicity[edit]
As with other opioids, M320 has the potential for abuse and addiction. Its use is strictly regulated in research environments to prevent misuse. Studies on its toxicity profile are ongoing to better understand its safety margins and potential adverse effects.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian